SUPERANTIBODIES that can bind to targets within cells, rather than on their surface, could lead to a new range of treatments for diseases, a biotech company claims. "Most good targets for diseases are ...

The new treatment approach targets restoring normal blood vessel function instead of focusing on neurons or other brain cells, which has been the common strategy until now. A team of scientists co-led ...

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under ...

Patients receiving intensive cancer treatments—such as radiation or stem cell transplantation—often suffer from severe damage ...

Researchers provide a comprehensive overview of the blood-brain barrier (BBB), detailing its cellular architecture, transport ...

Among owners and advocates of zero-emission vehicles, few topics generate as much back-and-forth debate (to put it politely) as those cars powered by hydrogen fuel cells. Discussions of ...

Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.